Through our research initiatives, we look to discover more effective ways to prevent, diagnose, and treat neurological diseases and disorders. We are deeply committed to our research mission, with many laboratories actively pursuing breakthroughs in neurobiology, stroke, multiple sclerosis, autism, epilepsy, Alzheimer's, spine and brain trauma, and behavioral neurosciences. A few of the most important discoveries are listed below:
In 1984, Prof. Paul Lauterbur of the Stony Brook Department of Chemistry constructed the first image using Nuclear Magnetic Resonance (MRI). This led to the awarding of the 2003 Nobel Prize in Medicine to Professor Lauterbur. The ability to perform non-invasive imaging of the interior of living organisms using MRI is one of the most important medical discoveries of the twentieth century.
In 1987, Dr. Dmitry Goldgaber of the Stony Brook Department of Psychiatry was the first to isolate, characterize, and determine the localization of human amyloid precursor protein to chromosome 21.
Stony Brook scientists were the first to isolate the spirochetal bacterium that causes Lyme disease from patients, and they developed the antibiotic regimen to combat Lyme disease.
Clinical researchers from the Stony Brook Comprehensive Spine Center have pioneered the adoption of bone morphogenic proteins in spinal surgery, which has dramatically reduced the need for painful bone graft harvesting.
Our researchers collaborate with investigators at the prestigious, Long Island research institutions of Brookhaven National Laboratory and the Cold Spring Harbor Laboratory. Stony Brook is one of the few public institutions to co-direct a national laboratory (BNL).
Neuroscience research at Stony Brook is primarily performed in the following departments and programs: